SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-23-000016
Filing Date
2023-02-02
Accepted
2023-02-02 16:06:43
Documents
14
Period of Report
2023-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20230202.htm   iXBRL 8-K 36967
2 EX-99.1 earningsrelease_q2fy23.htm EX-99.1 261774
6 logoa18.jpg GRAPHIC 6462
  Complete submission text file 0000849146-23-000016.txt   467823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20230202.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20230202_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20230202_pre.xml EX-101.PRE 13064
8 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20230202_htm.xml XML 11236
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 23580893
SIC: 2834 Pharmaceutical Preparations